Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Mar;26(2):119-126.
doi: 10.1080/1354750X.2021.1874052. Epub 2021 Jan 18.

Biomarkers and short-term prognosis in COVID-19

Affiliations
Observational Study

Biomarkers and short-term prognosis in COVID-19

Óscar M Peiró et al. Biomarkers. 2021 Mar.

Abstract

Purpose: The aim of our study was to analyse the short-term prognostic value of different biomarkers in patients with COVID-19.

Methods: We included patients admitted to emergency department with COVID-19 and available concentrations of cardiac troponin I (cTnI), D-dimer, C-reactive protein (CRP) and lactate dehydrogenase (LDH). Patients were classified for each biomarker into two groups (low vs. high concentrations) according to their best cut-off point, and 30-day all-cause death was evaluated.

Results: After multivariate adjustment, cTnI ≥21 ng/L, D-dimer ≥1112 ng/mL, CRP ≥10 mg/dL and LDH ≥334 U/L at admission were associated with an increased risk of 30-day all-cause death (hazard ratio (HR) 4.30; 95% CI 1.74-10.58; p = 0.002; HR 3.35; 95% CI 1.58-7.13; p = 0.002; HR 2.25; 95% CI 1.13-4.50; p = 0.021; HR 2.00; 95% CI 1.04-3.84; p = 0.039, respectively). The area under the curve for cTnI was 0.825 (95% CI 0.759-0.892) and, in comparison, was significantly better than CRP (0.685; 95% CI 0.600-0.770; p = 0.009) and LDH (0.643; 95% CI 0.534-0.753; p = 0.006) but non-significantly better than D-dimer (0.756; 95% CI 0.674-0.837; p = 0.115).

Conclusions: In patients with COVID-19, increased concentrations of cTnI, D-dimer, CRP and LDH are associated with short-term mortality. Of these, cTnI provides better mortality risk prediction. However, differences with D-dimer were non-significant.

Keywords: Biomarkers; C-reactive protein; COVID-19; D-dimer; lactate dehydrogenase; short-term prognosis; troponin.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Flow diagram of patients.
Figure 2.
Figure 2.
All-cause death cumulative survival by cTnI, D-dimer, CRP and LDH.
Figure 3.
Figure 3.
ROC curves for predicting all-cause death.

References

    1. Aboughdir, M., et al. , 2020. Prognostic value of cardiovascular biomarkers in COVID-19: a review. Viruses, 12 (5), 527. - PMC - PubMed
    1. Bardaji, A., et al. , 2015. Troponina elevada en pacientes sin síndrome coronario agudo. Revista española de cardiología, 68 (6), 469–476. - PubMed
    1. Chen, T., et al. , 2020. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ (clinical research ed.), 368, m1091. - PMC - PubMed
    1. DeLong, E.R., DeLong, D.M., and Clarke-Pearson, D.L., 1988. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics, 44 (3), 837–845. - PubMed
    1. Deng, X., et al. , 2020. Blood biochemical characteristics of patients with coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis. Clinical chemistry and laboratory medicine, 58 (8), 1172–1181. - PubMed

Publication types

MeSH terms